fingolimod hydrochloride has been researched along with Tachycardia, Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aburahma, A; Al Hadidi, S; Alkotob, ML; Elounais, F | 1 |
| Alarcón-Duque, JA; Castillo-Trivino, T; Lopetegui, I; López de Munain, A; Olascoaga, J | 1 |
2 other study(ies) available for fingolimod hydrochloride and Tachycardia, Ventricular
| Article | Year |
|---|---|
Ventricular tachycardia after initiation of fingolimod.
Topics: Diagnosis, Differential; Electrocardiography; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Tachycardia, Ventricular | 2017 |
Ventricular tachycardia on chronic fingolimod treatment for multiple sclerosis.
Topics: Adult; Electrocardiography, Ambulatory; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Multiple Sclerosis; Propylene Glycols; Sphingosine; Tachycardia, Ventricular | 2015 |